Showing results (301-310 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|March 15, 2011
Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptorKaleeckal G Harikumar, Erin E Cawston, Laurence J Miller
Assay and Drug Development Technologies|May 13, 2011
A facilitated approach to evaluate the inhibitor mode and potency of compounds targeting microsomal prostaglandin e synthase-1Linda Spahiu, Patric Stenberg, Charlotte Larsson, et al.
Assay and Drug Development Technologies|May 13, 2011
High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometryRamona F Curpan, Peter C Simons, Dayong Zhai, et al.
Assay and Drug Development Technologies|March 29, 2011
Validation of an optical microplate label-free platform in the screening of chemical libraries for direct binding to a nuclear receptorLaura Vela, Peter N Lowe, John Gerstenmaier, et al.
Assay and Drug Development Technologies|May 27, 2011
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disordersKenneth J Valenzano, Richie Khanna, Allan C Powe, et al.
Assay and Drug Development Technologies|June 17, 2011
Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp dataOlaf Scheel, Herbert Himmel, Gesa Rascher-Eggstein, et al.
Assay and Drug Development Technologies|February 18, 2011
Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptorsEllen E Codd, John R Mabus, Brian S Murray, et al.
Assay and Drug Development Technologies|December 17, 2010
A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channelWilliam A Schmalhofer, Andrew M Swensen, Brande S Thomas, et al.
Pageof 100